Coexistence of superficial carcinogenesis of resident epithelium besides neuroendocrine neoplasm of the digestive tract.
MiNEN
NEC
NET
bystander effect
neuroendocrine carcinoma
Journal
Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
revised:
05
09
2021
received:
08
03
2021
accepted:
11
09
2021
pubmed:
21
1
2022
medline:
19
4
2022
entrez:
20
1
2022
Statut:
ppublish
Résumé
Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) is a rare neuroendocrine neoplasm (NEN) comprising dual neuroendocrine and non-neuroendocrine components. Although the coexistence pattern of neuroendocrine and non-neuroendocrine components in definitive MiNEN is thought to overlap, there may be a coexistent pattern of both components, such as superficial carcinoma adjacent to NEN. The present study evaluated the histopathological findings of the coexistence pattern of superficial carcinomas adjacent to NENs in the esophagogastrointestinal tract. From 2000 to 2019, 35 serial NEN resections of the esophagus (n = 9), stomach (n = 3), and large intestine (n = 23), respectively, were performed at Gunma University Hospital. Borderline areas between NEN and resident superficial epithelium were observed in the 35 serial NEN cases as well as two additional cases from affiliated hospitals. Among the 35 serial NEN samples, squamous cell carcinomatous/dysplastic components were identified 77.8% (7/9 cases) of esophageal NENs, and adenocarcinomatous areas were seen in 66.7% (2/3 cases) of gastric NENs and 26% (6/23 cases) of colorectal NENs. Thus, all superficial carcinomatous components adjacent to NENs were observed as squamous cell carcinoma/dysplasia in esophagus and adenocarcinoma in stomach and large intestine, which showed histological characteristics as the resident epithelial pattern in each organ. These findings suggested a potential "paratransformation" or "bystander effect" in resident epithelium by NENs. Thus, "bystander carcinogenesis" could be a pathogenic mechanism of resident epithelium transformation adjacent to NENs in the esophagogastrointestinal tract.
Sections du résumé
BACKGROUND & AIMS
Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) is a rare neuroendocrine neoplasm (NEN) comprising dual neuroendocrine and non-neuroendocrine components. Although the coexistence pattern of neuroendocrine and non-neuroendocrine components in definitive MiNEN is thought to overlap, there may be a coexistent pattern of both components, such as superficial carcinoma adjacent to NEN. The present study evaluated the histopathological findings of the coexistence pattern of superficial carcinomas adjacent to NENs in the esophagogastrointestinal tract.
METHODS
From 2000 to 2019, 35 serial NEN resections of the esophagus (n = 9), stomach (n = 3), and large intestine (n = 23), respectively, were performed at Gunma University Hospital. Borderline areas between NEN and resident superficial epithelium were observed in the 35 serial NEN cases as well as two additional cases from affiliated hospitals.
RESULTS
Among the 35 serial NEN samples, squamous cell carcinomatous/dysplastic components were identified 77.8% (7/9 cases) of esophageal NENs, and adenocarcinomatous areas were seen in 66.7% (2/3 cases) of gastric NENs and 26% (6/23 cases) of colorectal NENs. Thus, all superficial carcinomatous components adjacent to NENs were observed as squamous cell carcinoma/dysplasia in esophagus and adenocarcinoma in stomach and large intestine, which showed histological characteristics as the resident epithelial pattern in each organ.
CONCLUSIONS
These findings suggested a potential "paratransformation" or "bystander effect" in resident epithelium by NENs. Thus, "bystander carcinogenesis" could be a pathogenic mechanism of resident epithelium transformation adjacent to NENs in the esophagogastrointestinal tract.
Identifiants
pubmed: 35048546
doi: 10.1002/cam4.4485
pmc: PMC8855898
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
983-992Subventions
Organisme : Japan Society for the Promotion of Science
ID : 20K09098
Organisme : Japan Society for the Promotion of Science
ID : 18K07665
Informations de copyright
© 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Références
Int J Oncol. 2003 Nov;23(5):1309-15
pubmed: 14532970
Dig Dis Sci. 2004 Nov-Dec;49(11-12):1912-21
pubmed: 15628725
Cancer. 1985 Aug 1;56(3):514-8
pubmed: 2988746
Am J Clin Pathol. 2016 May;145(5):703-9
pubmed: 27124941
Cancer Res. 2000 Aug 1;60(15):3989-99
pubmed: 10945596
Cancer. 1988 Apr 15;61(8):1635-8
pubmed: 3349423
Histopathology. 2020 Jan;76(2):182-188
pubmed: 31433515
Eur J Cancer. 1997 Jun;33(7):1005-16
pubmed: 9376180
FEBS Lett. 2014 Apr 17;588(8):1230-7
pubmed: 24492007
Surg Today. 2020 Sep;50(9):1099-1106
pubmed: 32052182
Virchows Arch. 2006 Nov;449(5):499-506
pubmed: 17033797
Oncotarget. 2018 Apr 6;9(26):18637-18647
pubmed: 29719632
Mutat Res. 2011 Aug 1;713(1-2):32-8
pubmed: 21645526
Eur J Surg Oncol. 1995 Oct;21(5):541-4
pubmed: 7589602
Science. 2004 Feb 13;303(5660):1007-10
pubmed: 14963329
Trends Cell Biol. 2008 Sep;18(9):414-20
pubmed: 18703335
Cancers (Basel). 2012 Jan 16;4(1):11-30
pubmed: 24213223
Cancer. 1988 Oct 15;62(8):1568-72
pubmed: 3167769
J Clin Med. 2020 Jan 19;9(1):
pubmed: 31963850
Blood. 2001 May 15;97(10):3075-85
pubmed: 11342433
Cancer. 1987 Feb 15;59(4):783-7
pubmed: 3802036
Cancer Res. 1992 Nov 15;52(22):6394-6
pubmed: 1423287
Neuroendocrinology. 2017;105(4):412-425
pubmed: 28803232
Sci Rep. 2019 Jun 24;9(1):9103
pubmed: 31235776
Int J Cancer. 1998 Oct 5;78(2):149-52
pubmed: 9754643
Cancer Med. 2022 Feb;11(4):983-992
pubmed: 35048546
Cancer Biol Ther. 2008 Jun;7(6):864-72
pubmed: 18340112